Encouraging Guidance on Clinical Program Makes Summit Therapeutics (SMMT) Look Attractive
On January 14, H.C. Wainwright analyst Mitchell Kapoor reaffirmed his optimistic outlook on Summit Therapeutics (NASDAQ:SMMT).
Summit Therapeutics Inc. (SMMT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 33,722,974 | $696,716,643 | 5.03% | |
| 2. | Polymer Capital Management Angus Yuk Chi Wai | 817,276 | $16,884,922 | -9% | 2.33% |
| 3. | 781,900 | $16,154,054 | -11% | 0.02% | |
| 4. | Polar Capital Brian Ashford-Russell And Tim Woolley | 746,393 | $15,420,479 | -26% | 0.07% |
| 5. | 726,400 | $15,007,424 | +85% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.74 | 533,617 | $9,999,982.58 | 32,057,147 | 2025-10-21 | Filing | |
| $18.74 | 26,680 | $499,983.20 | 76,680 | 2025-10-21 | Filing | |
| $18.74 | 26,680 | $499,983.20 | 76,680 | 2025-10-21 | Filing | |
| $18.07 | 5,000 | $90,350.00 | 556,093,090 | 2025-09-11 | Filing | |
| $17.68 | 333,394 | $5,894,405.92 | 556,088,090 | 2025-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 13,713 | $60,885.72 | 0 | 2020-11-30 | Filing | |
| $4.39 | 29,569 | $129,807.91 | 0 | 2020-11-27 | Filing | |
| $4.32 | 12,070 | $52,142.40 | 0 | 2020-11-25 | Filing | |
| $4.21 | 11,374 | $47,884.54 | 0 | 2020-11-24 | Filing | |
| $4.40 | 6,987 | $30,742.80 | 0 | 2020-11-23 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 927,171 | $16,216,221 | 0.03% | |
| 2. | 95,782 | $1,675,227 | 0.13% | |
| 3. | 59,621 | $1,042,771 | 0% | |
| 4. | 59,430 | $1,039,431 | 0.3% | |
| 5. | 57,282 | $1,001,862 | 0.01% |
News See All
15 Large Cap Stocks Under $100 With Huge Upside Potential
The large-cap stock universe comprises mature companies with market capitalizations ranging between $10 billion and $200 billion.
Cantor Fitzgerald Reaffirms Overweight Rating on Summit Therapeutics (SMMT) Before Key 2026 Catalyst
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the best stocks under $25 to buy now. Cantor Fitzgerald reaffirmed its Overweight rating on Summit Therapeutics Inc.
15 Best Stocks Under $25 to Buy Now
Stock futures were marginally lower early December 29, as traders grabbed profits at record index levels and exited prominent technology names and precious metals following an explosive rally.
Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best biotech stocks to buy according to Wall Street analysts.
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
Summit Therapeutics (SMMT) Reports Positive Results from the Phase III HARMONi Trial
The study tested ivonescimab, an innovative bispecific antibody, combining it with platinum-doublet chemotherapy in patients whose lung cancer had a specific genetic mutation (EGFR) and whose cancer was...
15 Stocks Set to Explode in 2026
While the market figures out whether artificial intelligence is driving the next bubble or the next industrial revolution, a quiet rotation of capital into the next wave of growth leaders outside Big ...
Summit Therapeutics (SMMT) Releases Financial Results and Updates on Operational Progress for Q3 2025
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the Stocks to Buy with Exponential Growth Heading into 2026.
13 Stocks to Buy with Exponential Growth Heading into 2026
As per Fidelity, the tax law that was passed over the summer is projected to reduce the effective corporate tax rate.
Hedge Fund Resource Center Billionaire Hedge Funds
